To Assess the Effect of AZD1722 on the Pharmacokinetics of Cefadroxil in Healthy Volunteers
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 28
Summary
- Conditions
- Healthy Volunteers
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
Participation Requirements
- Age
- Younger than 50 years
- Gender
- Both males and females
Description
A Phase 1, Single-center, Randomized, 2-Way Cross-over, Open-label Study to Evaluate the Effect of Oral Repeated Doses of AZD1722 on the Pharmacokinetics of Oral Cefadroxil in Healthy Volunteers
A Phase 1, Single-center, Randomized, 2-Way Cross-over, Open-label Study to Evaluate the Effect of Oral Repeated Doses of AZD1722 on the Pharmacokinetics of Oral Cefadroxil in Healthy Volunteers
Tracking Information
- NCT #
- NCT02140281
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Eleanor - Lisbon, MD Quintiles, Overland Park, Kansas
- Eleanor - Lisbon, MD Quintiles, Overland Park, Kansas
Get Well Soon